Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

02 Mar 2023
// Amber Tong ENDPTS
https://endpts.com/novo-nordisk-offloads-preclinical-cancer-candidate-from-1-1b-forma-buyout-debiopharm/

03 Dec 2022
// Christopher Newman BIOPHARMADIVE
https://www.biopharmadive.com/news/rigel-pharmaceuticals-leukemia-rezlidhia-fda-approval/637843/

14 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/14/2534660/0/en/Novo-Nordisk-announces-the-completion-of-the-Forma-Therapeutics-acquisition.html

01 Sep 2022
// PRESS RELEASE
https://ir.formatherapeutics.com/news-releases/news-release-details/novo-nordisk-acquire-forma-therapeutics-and-expand-presence

05 Aug 2022
// BUSINESSWIRE

02 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-and-forma-therapeutics-announce-licensing-agreement-for-olutasidenib-a-novel-mutant-idh1-inhibitor-for-the-potential-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia-301598297.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE